socalTechnews
Log in | Join | Subscribe

Home
Mobile
News and Events
  • Headlines
  • Events
  • Interviews
  • Jobs
  • Directory
    		•
    Members Only
  • Networking
  • Venture Deals
  • Venture Firms
  • Companies
    • About
  • Membership
  • About
  • Contact Us
    		•

    Search News
    Wednesday, October 25, 2006

    Amgen Completes Avidia Acquisition
    Thousand Oaks-based Amgen has completed its acquisition of Mountain View-based Avidia, the firm said Tuesday afternoon. The previously announced acquisition was worth $290M. Avidia's lead product candidate is an inhibitor of interleukin 6, targeted at the treatment of inflammation and autoimmune diseases.
    posted on Wednesday, October 25, 2006

    Related companies:
    Amgen

    Related stories:
    > Amgen Acquires Avidia
    > Amgen Completes Alantos Acquisition
    > Amgen Makes $1.3B Acquisition
    > Amgen Spins Out Biotech Firm
    > Amgen Creates $100M VC Arm

    RSS subscri be via emailEmail Twitter


    Previous news:

     Thursday, November 20, 2008
    Wednesday, November 19, 2008
    Tuesday, November 18, 2008
    Monday, November 17, 2008
    Friday, November 14, 2008